Skip to main content

Table 3 Summary of immunohistochemical staining

From: Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?

SAMPLES ID PRIMARY MAMMARY TUMOR LYMPH NODE METASTASIS
  ER* PR* c-erbB-2° CK 14* CK 5/6* p63* ER* PR* c-erbB-2° CK 14* CK 5/6* p63*
1 1 1 1 1 1 0 0 1 1 1 1 0
2 0 1 1 1 1 0 0 1 1 1 1 0
3 1 0 1 1 1 1 0 0 0 0 0 0
4 0 0 1 1 1 0 0 0 1 1 1 0
5 0 1 3 1 1 1 0 1 3 1 1 0
6 1 0 1 1 1 1 0 0 1 1 1 1
7 1 1 1 1 1 1 1 1 0 1 1 0
8 0 1 1 1 1 0 0 0 1 1 1 0
9 1 1 3 1 1 1 0 0 3 1 1 0
10 1 1 3 1 1 1 1 1 3 1 1 0
11 0 0 1 1 0 0 0 0 1 1 0 0
12 1 0 2 1 1 1 0 0 1 1 1 0
13 1 0 2 1 1 1 0 0 1 0 0 0
14 1 1 1 1 1 0 1 0 1 1 1 0
15 0 0 2 1 1 0 0 0 3 1 1 0
16 1 0 1 1 1 0 1 0 1 0 1 0
17 0 1 2 1 1 0 0 1 2 1 1 0
18 0 0 2 1 1 1 0 0 2 0 0 0
19 0 0 1 1 1 0 0 0 1 1 1 0
20 0 1 2 1 1 1 0 0 2 1 1 1
  1. *ER, PR, CK5/6, CK14, p63: 0= no immunoreactivity; 1= immunoreactivity. °c-erbB-2: 0= no immunoreactivity; 1= <10% positive cells; 2= 10 to 90% complete membranous immunostaining; 3= >90% complete membranous cell positivity.